Fred Hutchinson Cancer Research Center is delighted to request applications for the 2017 CTI BioPharma International Postdoctoral Research Fellowship, which is an endowed visiting fellowship for physician scientists with an emphasis on hematologic malignancies. This announcement is being circulated to all potential sponsoring scientists including all heads of laboratories, research faculty, and other potential postdoctoral mentors at Fred Hutch. This International postdoctoral research fellowship honors the efforts and historic work of Fred Hutch’s Dr. E. Donnall Thomas (1920-2012), father of bone marrow transplantation and 1990 Nobel laureate in physiology or medicine.
This fellowship opportunity is intended to invite visiting physician-scientists to the Fred Hutch Clinical Research Division to advance translational science among institutions around the world and foster international collaboration in translational research in blood related cancers and immune-biology. Visiting physician-scientists will be appointed for one-year terms, which can be renewed. Preference will be given to foreign physician-scientists.
Fellowship Available: One fellowship for one year, which can be renewed
Application Deadline: Feb. 17, 2017
The fellowship may be used to cover salary and/or to supplement salary. Recipients may already be at Fred Hutch or may be recruited to the Hutch with funds from this fellowship. Recipients should demonstrate their high-impact accomplishments in translational research and the potential for an independent scientific career. The CTI BioPharma International Postdoctoral Research Fellowship is intended to foster international collaboration in translational research in blood-related cancers and immunobiology.